Literature DB >> 32140818

US detection of medial meniscus extrusion can predict the risk of developing radiographic knee osteoarthritis: a 5-year cohort study.

Daisuke Chiba1, Eiji Sasaki2, Seiya Ota2, Shugo Maeda2, Daisuke Sugiyama3, Shigeyuki Nakaji4, Yasuyuki Ishibashi2.   

Abstract

OBJECTIVES: To clarify the relationship between the baseline value of medial meniscus extrusion (MME) and the radiographic change of knee osteoarthritis (KOA) through a 5-year follow-up.
METHODS: Overall, 472 participants and 944 knees were eligible. MME (mm) was measured at the baseline, and KOA was radiographically evaluated at both baseline and 5-year follow-up by Kellgren-Lawrence grade (KLG). Radiographic KOA (ROA) was defined as the knee showing KLG ≥ 2. Incident ROA (iROA) was defined if the baseline KLG of 0-1 increased to KLG ≥ 2 in 5 years. Progressive ROA (pROA) was defined if the baseline KLG of 2-3 worsened to a higher grade in 5 years. Receiver operating characteristic (ROC) curve and generalized estimating equations were used for analysis.
RESULTS: Of 574 non-ROA knees at the baseline, 43 knees (7.5%) developed iROA; of 370 ROA knees, 47 knees (12.7%) developed pROA. Based on the ROC curves, 4 mm was the optimal cutoff to detect the risk of iROA (area under curve [AUC] 0.639 [right knee]; AUC 0.641 [left knee]) and that of pROA (AUC 0.750 [right knee]; AUC 0.863 [left knee]). Multiple regression analysis showed that the 4-mm cutoff of MME was significantly associated with both the prevalence of iROA (regression coefficient [B] 1.909; p ≤ 0.001; adjusted odds ratio [aOR] 6.746) and that of pROA (B 1.791; p ≤ 0.001; aOR 5.993).
CONCLUSIONS: On ultrasonography, the participants with more extruded medial meniscus showed a higher prevalence of both iROA and pROA. Ultrasonography could identify patients who had a risk of developing KOA. KEY POINTS: • Through a 5-year follow-up, the current cohort study was conducted to clarify the relationship between the baseline value of medial meniscus extrusion (MME) and the radiographic change of knee osteoarthritis (KOA). • More extruded medial meniscus evaluated by ultrasonography was associated with the development of radiographic KOA. • Ultrasonography could identify the patients who had a risk of developing KOA, and the 4-mm cutoff of MME was optimal to detect this risk.

Entities:  

Keywords:  Cohort study; Knee osteoarthritis; Meniscus; Ultrasound

Year:  2020        PMID: 32140818     DOI: 10.1007/s00330-020-06749-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

Review 1.  Clinical significance and management of meniscal extrusion in different knee pathologies: a comprehensive review of the literature and treatment algorithm.

Authors:  Konstantinos G Makiev; Ioannis S Vasios; Paraskevas Georgoulas; Konstantinos Tilkeridis; Georgios Drosos; Athanasios Ververidis
Journal:  Knee Surg Relat Res       Date:  2022-07-18

2.  Reduced serum levels of anti-Mullerian hormone is a putative biomarker of early knee osteoarthritis in middle-aged females at menopausal transition.

Authors:  Eiji Sasaki; Daisuke Chiba; Seiya Ota; Yuka Kimura; Shizuka Sasaki; Yuji Yamamoto; Maika Oishi; Kaori Iino; Masataka Ando; Eiichi Tsuda; Yasuyuki Ishibashi
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

3.  Greater medial meniscus extrusion seen on ultrasonography indicates the risk of MRI-detected complete medial meniscus posterior root tear in a Japanese population with knee pain.

Authors:  Daisuke Chiba; Tomoyuki Sasaki; Yasuyuki Ishibashi
Journal:  Sci Rep       Date:  2022-03-19       Impact factor: 4.379

4.  Determining a Threshold of Medial Meniscal Extrusion for Prediction of Knee Pain and Cartilage Damage Progression Over 4 Years: Data From the Osteoarthritis Initiative.

Authors:  Yao Liu; Gabby B Joseph; Sarah C Foreman; Xiaoming Li; Nancy E Lane; Michael C Nevitt; Charles E McCulloch; Thomas M Link
Journal:  AJR Am J Roentgenol       Date:  2020-07-29       Impact factor: 3.959

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.